Trademark Overview
On Tuesday, November 25, 2003, a trademark application was filed for REGALIX with the United States Patent and Trademark Office. The USPTO has given the REGALIX trademark a serial number of 78332822. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, May 13, 2005. This trademark is owned by Pfizer Inc.. The REGALIX trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, sleep disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations